Ovid Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 10.71 M | $17.46 M | 100.00% | 15.07% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 7.15 M | $11.65 M | 169.81% | 10.05% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 4.29 M | $6.98 M | 100.00% | 6.03% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 4.29 M | $6.98 M | 33,256.69% | 6.03% |
| FEDERATED HERMES, INC. | 02/12/2026 | 3.57 M | $5.31 M | 100.00% | 5.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 3.49 M | $5.69 M | 158.67% | 4.91% |
| VANGUARD GROUP INC | 01/29/2026 | 3.07 M | $5.01 M | 8.91% | 4.32% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.50 M | $4.08 M | 100.00% | 3.52% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.48 M | $2.42 M | -26.44% | 2.09% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 1.43 M | $2.33 M | 0.00% | 2.01% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.34 M | $2.18 M | 35.81% | 1.88% |
| MARSHALL WACE, LLP | 02/13/2026 | 1.27 M | $2.07 M | 62.25% | 1.79% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 1.23 M | $2.01 M | -46.13% | 1.73% |
| AWM INVESTMENT COMPANY, INC. | 02/13/2026 | 899.20 K | $1.47 M | 100.00% | 1.26% |
| JANE STREET GROUP, LLC | 02/12/2026 | 883.87 K | $1.44 M | 270.73% | 1.24% |
| CITADEL ADVISORS LLC | 02/17/2026 | 797.82 K | $1.30 M | 96.81% | 1.12% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 720.85 K | $1.17 M | -1.35% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 672.00 K | $1.10 M | 3.70% | 0.95% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 618.02 K | $1.01 M | -33.16% | 0.87% |
| BLACKROCK, INC. | 02/12/2026 | 613.48 K | $999.96 K | 0.35% | 0.86% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 598.87 K | $976.16 K | 75.55% | 0.84% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 530.02 K | $863.93 K | -11.18% | 0.75% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 341.74 K | $557.04 K | -41.99% | 0.48% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 325.00 K | $529.75 K | -48.00% | 0.46% |
| STATE STREET CORP | 02/13/2026 | 276.53 K | $450.75 K | 21.80% | 0.39% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 239.20 K | $389.90 K | 57.58% | 0.34% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 201.04 K | $327.69 K | -0.96% | 0.28% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 194.90 K | $317.69 K | -46.27% | 0.27% |
| UBS GROUP AG | 01/29/2026 | 192.99 K | $314.57 K | -18.91% | 0.27% |
| XTX TOPCO LTD | 02/17/2026 | 188.46 K | $307.18 K | 2.81% | 0.27% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 170.46 K | $277.85 K | 497.74% | 0.24% |
| NORTHERN TRUST CORP | 02/17/2026 | 166.63 K | $271.61 K | 9.83% | 0.23% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/13/2026 | 160.00 K | $260.80 K | 0.00% | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 155.74 K | $253.86 K | -68.01% | 0.22% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 127.46 K | $207.76 K | 100.00% | 0.18% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 125.30 K | $204.24 K | 100.00% | 0.18% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 108.33 K | $177.00 K | -59.27% | 0.15% |
| CITADEL ADVISORS LLC | 02/17/2026 | 106.90 K | $174.25 K | 36.18% | 0.15% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 102.37 K | $166.86 K | 100.00% | 0.14% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 95.43 K | $155.56 K | 0.00% | 0.13% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 87.87 K | $143.24 K | 217.20% | 0.12% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 57.70 K | $94.05 K | 0.00% | 0.08% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 53.95 K | $87.94 K | 113.44% | 0.08% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 39.03 K | $63.63 K | -66.03% | 0.05% |
| MORGAN STANLEY | 02/13/2026 | 36.95 K | $60.23 K | 1,496.89% | 0.05% |
| INVESCO LTD. | 02/19/2026 | 33.31 K | $54.29 K | 100.00% | 0.05% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 31.60 K | $51.51 K | -91.84% | 0.04% |
| ABEL HALL, LLC | 02/17/2026 | 31.43 K | $51.23 K | -2.85% | 0.04% |
| LPL FINANCIAL LLC | 02/11/2026 | 30.00 K | $48.90 K | 150.00% | 0.04% |
| TOTAL CLARITY WEALTH MANAGEMENT, INC. | 02/02/2026 | 28.60 K | $46.62 K | 100.00% | 0.04% |
Ovid Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 95 institutional investors and hedge funds held shares of Ovid Therapeutics Inc. The most heavily invested institutionals were:
Affinity Asset Advisors, LLC: 7.15 M
EVENTIDE ASSET MANAGEMENT, LLC: 4.29 M
FEDERATED HERMES, INC.: 3.57 M
VANGUARD GROUP INC: 3.07 M
RENAISSANCE TECHNOLOGIES LLC: 1.48 M
MILLENNIUM MANAGEMENT LLC: 1.34 M
87.01% of Ovid Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 46.38 M shares in the last 24 months. This purchase volume represents approximately $68.18 M in transactions.